Literature DB >> 10628489

Tubular carcinoma of the breast: mammographic and sonographic features.

D G Sheppard1, G J Whitman, P T Huynh, A A Sahin, B D Fornage, C B Stelling.   

Abstract

OBJECTIVE: The purpose of this study was to define specific mammographic and sonographic features of tubular carcinoma of the breast.
MATERIALS AND METHODS: Seventeen pathologically confirmed cases of tubular carcinoma were characterized retrospectively by two radiologists. Mammograms and sonograms were available for all patients.
RESULTS: Fifteen of the 17 tubular carcinomas appeared as irregularly shaped masses with spiculated margins on mammography. Sixteen of the 17 masses had central densities. Spicules longer than the diameter of the central lesion were noted in eight (53%) of 15 tubular carcinomas. Eight tubular carcinomas had associated calcifications, with calcifications suspected of being malignant in four cases. On sonography, 15 hypoechoic masses were seen. The margins of the masses on sonography were described as ill-defined in 14 (93%) of the 15 cases. Posterior acoustic shadowing was present in 14 of the 15 cases.
CONCLUSION: Tubular carcinomas are usually seen on mammography as irregularly shaped masses with central densities and spiculated margins, and most tubular carcinomas can be identified on sonography as hypoechoic masses with ill-defined margins and posterior acoustic shadowing. Although the mammographic and sonographic features of tubular carcinoma are not sufficiently specific to differentiate tubular carcinomas from radial scars, sonography can be useful for guiding biopsies and evaluating for multifocal and multicentric disease.

Entities:  

Mesh:

Year:  2000        PMID: 10628489     DOI: 10.2214/ajr.174.1.1740253

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  CAD for mammography: the technique, results, current role and further developments.

Authors:  Ansgar Malich; Dorothee R Fischer; Joachim Böttcher
Journal:  Eur Radiol       Date:  2006-01-17       Impact factor: 5.315

2.  Breast cancer subtypes: morphologic and biologic characterization.

Authors:  Shahla Masood
Journal:  Womens Health (Lond)       Date:  2016-01-12

3.  Sonographic correlations with the new molecular classification of invasive breast cancer.

Authors:  I T H Au-Yong; A J Evans; S Taneja; E A Rakha; A R Green; C Paish; I O Ellis
Journal:  Eur Radiol       Date:  2009-05-14       Impact factor: 5.315

4.  MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses.

Authors:  Ravza Yılmaz; Zuhal Bayramoğlu; Selman Emirikçi; Semen Önder; Artur Salmaslıoğlu; Memduh Dursun; Gülden Acunaş; Vahit Özmen
Journal:  Eur J Breast Health       Date:  2018-01-01

5.  Rare types of breast carcinoma.

Authors:  Daiva Gudaviciene; Laura Steponaviciene; Raimundas Meskauskas; Giedre Smailyte; Eduardas Aleknavicius
Journal:  Open Med (Wars)       Date:  2014-11-24

6.  Tubular Carcinoma of the Breast: Advantages and Limitations of Breast Tomosynthesis.

Authors:  Filipa Vilaverde; Ana Rocha; Alcinda Reis
Journal:  Case Rep Radiol       Date:  2016-12-26

7.  Pure and Mixed Tubular Carcinoma of the Breast: Mammographic Features, Clinicopathological Characteristics and Prognostic Analysis.

Authors:  Chanjuan Wen; Weimin Xu; Genggeng Qin; Hui Zeng; Zilong He; Sina Wang; Zeyuan Xu; Mengwei Ma; Zhendong Luo; Weiguo Chen
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

8.  Pure and mixed tubular carcinoma of the breast: mammographic and sonographic differential features.

Authors:  Hee Jung Shin; Hak Hee Kim; Sun Mi Kim; Dae Bong Kim; Ye Ri Lee; Mi-Jung Kim; Gyungyub Gong
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

9.  Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jia-Yuan Sun; Feng-Yan Li; Yong-Xiong Chen; Zhen-Yu He
Journal:  Front Oncol       Date:  2018-05-30       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.